CJC-1295 DAC / Ipamorelin (5mg / 5mg) is a synergistic combination of two complementary growth hormone secretagogues, widely used in GH axis research for their additive effects on GH release and IGF-1 modulation.
Dual-peptide combination for comprehensive GH axis research
Ipamorelin adds selective ghrelin receptor agonism with minimal side effects
Studied for synergistic effects on lean mass and metabolic biology
How It Works: The combination targets two distinct pathways simultaneously — GHRH and ghrelin receptor signaling — producing a more robust and sustained GH pulse in research models than either compound alone.
Usage Note: For laboratory research use only. Design experimental protocols based on published combination peptide pharmacology studies.
This product is intended for research purposes only. Not for human consumption. Please store properly and handle with care.
